Cristal Therapeutics

About:

Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies.

Website: http://cristaltherapeutics.com/

Twitter/X: cristaltherap

Top Investors: BOM, EASME - EU Executive Agency for SMEs, BioGeneration Ventures, Horizon 2020, Thuja Capital

Description:

Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies. It aims to find valuable solutions for medical needs by creating superior drug products. Both new and existing drugs can be combined with Cristal Therapeutics Polymeric Technologies, shortly abbreviated as CriPec. CriPec-based products are versatile as a crystal and allow to improve the treatment of various diseases.

Total Funding Amount:

23.8M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Maastricht, Limburg, The Netherlands

Founded Date:

2011-01-01

Contact Email:

info(AT)cristaltherapeutics.com

Founders:

Cristianne Rijcken, Joost Holthuis

Number of Employees:

1-10

Last Funding Date:

2017-11-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai